Alexandria Real Estate Equities, Inc. (NYSE:ARE)

CAPS Rating: 1 out of 5

The Company is engaged principally in the ownership, operation, management, selective redevelopment, development and acquisition of properties for the life sciences industry.

Recs

1
Player Avatar SanFranFan (73.49) Submitted: 3/24/2007 2:42:12 AM : Outperform Start Price: $86.01 ARE Score: -16.27

ARE is building out BioTech Space in San Francisco's Mission Bay ahead of schedule. Biotech is booming, and San Francisco is where it's happening. ARE is in the right place at the right time.

Featured Broker Partners


Advertisement